PRECIGEN, INC. Financing Cash Flow
PRECIGEN, INC. (PGEN) reported Financing Cash Flow of $76.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-04
- PRECIGEN, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$33.00K.
- PRECIGEN, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $109.00K.
- PRECIGEN, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$514.00K, a 100.66% decline year-over-year.
- PRECIGEN, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $93.01M, a 189.50% increase year-over-year.
- PRECIGEN, INC. net cash provided by (used in) financing activities for fiscal 2025 was $90.05M, a 18.57% decline from fiscal 2024.
- PRECIGEN, INC. net cash provided by (used in) financing activities for fiscal 2024 was $110.58M, a 273.73% increase from fiscal 2023.
- PRECIGEN, INC. net cash provided by (used in) financing activities for fiscal 2023 was $29.59M.
- PRECIGEN, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$155.29M, a 228.14% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $76.00K 10-Q · filed 2026-08-04 | -$438.00K derived: sum of 3 quarters · filed 2026-08-04 | $92.57M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $109.00K 10-Q · filed 2026-05-13 | -$405.00K derived: sum of 2 quarters · filed 2026-05-13 | $92.60M derived: sum of 3 quarters · filed 2026-05-13 | $90.84M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | -$514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $92.49M derived: sum of 2 quarters · filed 2026-03-25 | $90.73M derived: sum of 3 quarters · filed 2026-08-04 | $90.05M 10-K · filed 2026-03-25 | |
| 2025-09-30 | $93.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $91.24M derived: sum of 2 quarters · filed 2026-08-04 | $90.56M 10-Q · filed 2025-11-13 | $168.97M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$2.44M 10-Q · filed 2026-08-04 | $75.96M derived: sum of 3 quarters · filed 2026-08-04 | $108.09M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | -$679.00K 10-Q · filed 2026-05-13 | $77.72M derived: sum of 2 quarters · filed 2026-05-13 | $109.85M derived: sum of 3 quarters · filed 2026-05-13 | $109.90M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $78.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $110.53M derived: sum of 2 quarters · filed 2026-03-25 | $110.58M derived: sum of 3 quarters · filed 2026-03-25 | $110.58M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $32.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $32.18M derived: sum of 2 quarters · filed 2025-11-13 | $32.18M 10-Q · filed 2025-11-13 | $32.18M derived: sum of 4 quarters · filed 2026-03-25 | |
| 2024-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $52.00K 10-Q · filed 2025-08-12 | $52.00K derived: sum of 3 quarters · filed 2026-03-25 | $52.00K derived: sum of 4 quarters · filed 2026-03-25 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | -$14.59M derived: sum of 4 quarters · filed 2026-03-25 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | -$14.59M derived: sum of 3 quarters · filed 2026-03-25 | $29.59M 10-K · filed 2026-03-25 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$14.59M derived: sum of 2 quarters · filed 2024-11-14 | $29.59M 10-Q · filed 2024-11-14 | -$9.69M derived: sum of 4 quarters · filed 2025-03-19 | |
| 2023-06-30 | -$14.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $29.59M 10-Q · filed 2024-08-14 | -$9.69M derived: sum of 3 quarters · filed 2025-03-19 | -$125.43M derived: sum of 4 quarters · filed 2025-03-19 | |
| 2023-03-31 | $44.17M 10-Q · filed 2024-05-14 | $4.89M derived: sum of 2 quarters · filed 2025-03-19 | -$110.84M derived: sum of 3 quarters · filed 2025-03-19 | -$110.95M derived: sum of 4 quarters · filed 2025-03-19 | |
| 2022-12-31 | -$39.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$155.02M derived: sum of 2 quarters · filed 2025-03-19 | -$155.13M derived: sum of 3 quarters · filed 2025-03-19 | -$155.29M 10-K · filed 2025-03-19 | |
| 2022-09-30 | -$115.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$115.85M derived: sum of 2 quarters · filed 2023-11-09 | -$116.01M 10-Q · filed 2023-11-09 | -$116.12M derived: sum of 4 quarters · filed 2024-03-19 | |
| 2022-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$276.00K 10-Q · filed 2023-08-09 | -$386.00K derived: sum of 3 quarters · filed 2024-03-19 | -$152.00K derived: sum of 4 quarters · filed 2024-03-19 | |
| 2022-03-31 | -$163.00K 10-Q · filed 2023-05-10 | -$273.00K derived: sum of 2 quarters · filed 2024-03-19 | -$39.00K derived: sum of 3 quarters · filed 2024-03-19 | -$16.00K derived: sum of 4 quarters · filed 2024-03-19 | |
| 2021-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $124.00K derived: sum of 2 quarters · filed 2024-03-19 | $147.00K derived: sum of 3 quarters · filed 2024-03-19 | $121.19M 10-K · filed 2024-03-19 | |
| 2021-09-30 | $234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $257.00K derived: sum of 2 quarters · filed 2022-11-09 | $121.30M 10-Q · filed 2022-11-09 | $121.22M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $121.06M 10-Q · filed 2022-08-08 | $120.99M derived: sum of 3 quarters · filed 2023-03-06 | $120.88M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-03-31 | $121.04M 10-Q · filed 2022-05-09 | $120.97M derived: sum of 2 quarters · filed 2023-03-06 | $120.85M derived: sum of 3 quarters · filed 2023-03-06 | $119.59M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2020-12-31 | -$72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$186.00K derived: sum of 2 quarters · filed 2023-03-06 | -$1.45M derived: sum of 3 quarters · filed 2023-03-06 | $32.70M 10-K · filed 2023-03-06 | |
| 2020-09-30 | -$114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$1.37M derived: sum of 2 quarters · filed 2021-11-08 | $32.78M 10-Q · filed 2021-11-08 | $33.98M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | -$1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $32.89M 10-Q · filed 2021-08-09 | $34.09M derived: sum of 3 quarters · filed 2022-03-01 | $34.13M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $34.15M 10-Q · filed 2021-05-10 | $35.35M derived: sum of 2 quarters · filed 2022-03-01 | $35.40M derived: sum of 3 quarters · filed 2022-03-01 | $35.36M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.24M derived: sum of 2 quarters · filed 2022-03-01 | $1.21M derived: sum of 3 quarters · filed 2022-03-01 | $8.14M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $12.00K derived: sum of 2 quarters · filed 2020-11-09 | $6.94M 10-Q · filed 2020-11-09 | $34.19M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $6.89M 10-Q · filed 2020-08-10 | $34.14M derived: sum of 3 quarters · filed 2021-03-01 | $227.74M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $6.93M 10-Q · filed 2020-05-11 | $34.18M derived: sum of 2 quarters · filed 2021-03-01 | $227.78M derived: sum of 3 quarters · filed 2021-03-01 | $228.46M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $27.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $220.85M derived: sum of 2 quarters · filed 2021-03-01 | $221.53M derived: sum of 3 quarters · filed 2021-03-01 | $309.80M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $193.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $194.28M derived: sum of 2 quarters · filed 2019-11-12 | $282.55M 10-Q · filed 2019-11-12 | $296.25M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $684.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $88.95M 10-Q · filed 2019-08-09 | $102.65M derived: sum of 3 quarters · filed 2020-03-02 | $95.97M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $88.26M 10-Q · filed 2019-05-09 | $101.97M derived: sum of 2 quarters · filed 2020-03-02 | $95.28M derived: sum of 3 quarters · filed 2020-03-02 | $95.69M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $13.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $7.02M derived: sum of 2 quarters · filed 2020-03-02 | $7.43M derived: sum of 3 quarters · filed 2020-03-02 | $4.28M 10-K · filed 2020-03-02 | |
| 2017-09-30 | -$6.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$6.27M derived: sum of 2 quarters · filed 2018-11-08 | -$9.42M 10-Q · filed 2018-11-08 | -$8.52M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | $408.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | -$2.74M 10-Q · filed 2018-08-13 | -$1.83M derived: sum of 3 quarters · filed 2019-03-01 | -$7.56M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | -$3.15M 10-Q/A · filed 2018-08-13 | -$2.24M derived: sum of 2 quarters · filed 2019-03-01 | -$7.97M derived: sum of 3 quarters · filed 2019-03-01 | -$673.00K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | $903.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$4.82M derived: sum of 2 quarters · filed 2019-03-01 | $2.47M derived: sum of 3 quarters · filed 2019-03-01 | $12.06M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$5.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.57M derived: sum of 2 quarters · filed 2017-11-09 | $11.16M 10-Q · filed 2017-11-09 | $11.40M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-06-30 | $7.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $16.89M 10-Q · filed 2017-08-09 | $17.13M derived: sum of 3 quarters · filed 2018-03-01 | $230.18M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-03-31 | $9.59M 10-Q · filed 2017-05-10 | $9.83M derived: sum of 2 quarters · filed 2018-03-01 | $222.89M derived: sum of 3 quarters · filed 2018-03-01 | $230.62M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-12-31 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $213.29M derived: sum of 2 quarters · filed 2018-03-01 | $221.02M derived: sum of 3 quarters · filed 2018-03-01 | $331.68M 10-K · filed 2018-03-01 | $333.25M 10-K · filed 2016-02-29 |
| 2015-09-30 | $213.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $220.78M derived: sum of 2 quarters · filed 2016-11-09 | $331.44M 10-Q · filed 2016-11-09 | $332.85M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $7.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $118.39M 10-Q · filed 2016-08-09 | $119.80M derived: sum of 3 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $110.66M 10-Q · filed 2016-05-10 | $112.07M derived: sum of 2 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $24.00M 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $22.59M 10-Q · filed 2015-11-09 | ||||
| 2013-12-31 | $472.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $169.47M derived: sum of 2 quarters · filed 2016-02-29 | $316.45M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $169.00M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07 | $315.98M 10-Q · filed 2013-11-07 | |||
| 2013-06-30 | $146.98M 10-Q/A · filed 2013-10-21 | ||||
| 2012-12-31 | $25.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $25.39M derived: sum of 2 quarters · filed 2015-03-02 | $75.94M 10-K · filed 2015-03-02 | ||
| 2012-09-30 | $199.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07 | $50.74M 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | $50.55M 10-Q/A · filed 2013-10-21 | ||||
| 2011-12-31 | $148.11M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |